- Investing Ideas
- Chinese Biotech Breakthroughs
Chinese Biotech Breakthroughs
Results
4
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
4 companies
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥25.8b
A commercial-stage biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.
688192
CN¥55.53
7D
-4.2%
1Y
-4.1%
Nanjing Vazyme Biotech
Market Cap: CN¥7.9b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥19.90
7D
6.4%
1Y
-9.8%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥11.3b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥30.80
7D
-1.7%
1Y
8.3%
Suzhou Zelgen Biopharmaceuticals
Market Cap: CN¥26.6b
Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.
688266
CN¥100.40
7D
-0.8%
1Y
-7.1%